David E. Koren, PharmD, MPH, BCPS, AAHIVP, FIDSA, Clinical Pharmacist Specialist in Infectious Diseases/HIV at Temple University Hospital (TUH), and T. Sam Albanesi, MD, Infectious Diseases Fellow at TUH, wrote an article for Contagion Live about lenacapavir, a new antiretroviral for the treatment of multi-drug resistant HIV-1 infection.
Update: Temple Health and Keystone First Family Health Plans have reached a new contract agreement.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH